期刊文献+

慢性肾衰竭的临床诊治研究 被引量:13

在线阅读 下载PDF
导出
摘要 目的研究慢性肾衰竭发生的原因及治疗措施的了解。方法收集肾衰竭患者的资料,按年龄、原发病和临床症状分组进行分析。结果 234例中原发病以慢性肾小球肾炎、急性肾炎和高血压为主,三者占总患者数的72%。依据患者的基础病变、营养状况、炎症情况、电解质平衡及透析时间等,及时调整治疗方案、合理用药能及时改善症状及预后。结论彻底的系统的对原发病的治疗是防范肾衰竭发生的重要措施,规律的血液透析和对症治疗是目前治疗肾衰竭的主要手段。在条件具备时,行肾移植术是改善肾衰竭患者生活质量的较好办法。
出处 《河北医药》 CAS 2011年第14期2118-2119,共2页 Hebei Medical Journal
  • 相关文献

参考文献12

  • 1Falk P,J, Jennette JC, Nachman PH. Primary Glomerular Disease. In: Brenner BM. The Kidney. 7th ed. Vol I. Philadelphia: Saunders, 2009. 1293-1380.
  • 2Schrier RW. Disease of the Kidney and Urinary Tract. Sth ed. Philadel- phia: Wolters Kluwer,2007.
  • 3Weisenssee D, Low-Friedrich L, Riehle M, et al. Invitro approah to ure-mic cardiomyopathy Nephron ,2010,65:392-400.
  • 4Saluaky IB, Goodman WG. Cardiovascular calcification in end-stage renal disease Neophrol Dial Transplant ,2008,17:336-339.
  • 5Marx GM, Blake GM, Galani E, et al. Evaluation of theCockcroft-Gault, Jelliffe and Wright formulae in estimating renal function in elderly cancer patients. Annals of Oncology ,2006,15:291-295.
  • 6Ritz E. The role of the parathyroid glands in the uremic syndrome Am J kidney Dis,2007,26:808-$13.
  • 7Portoles J. The beneficial effects of intervention in early renal disease. Nephrol Dial Transplant ,2010,16 : 12-15.
  • 8李劲高 宛霞.尿毒症患者血液透析中的出血倾向[J].广东医学,2008,21:1075-1075.
  • 9刘春艳,贾长绪.尿毒症血清对大鼠心肌损害的研究[J].中华肾脏病杂志,1999,15(2):118-119. 被引量:7
  • 10蒋建平,侯凡凡,高丽真,潘阳彬,杨念生,陈葳,舒贵扬,陈友明,陈建,彭卫华,吴建平,杨忠民.早期纠正贫血对慢性肾衰竭心血管病变影响的多中心临床研究[J].中华内科杂志,2005,40(1):25-29. 被引量:11

二级参考文献10

  • 1Stein G, Busch M, Muller A, et al. Are advanced glycation end products cardiovascular risk factors in patients with CRF? Am J Kidney Dis,2003,41 (3 Suppl 1 ) :S52-S56.
  • 2London GM. Left ventricular hypertrophy: why does it happen?Nephrol Dial Transplant,2003,18 Suppl 8 :viii2- viii6.
  • 3Heyman SN, Rosenberger C, Rosen S. Erythropoietin : a potential remedy for renal tubular injury7. Kidney Int,2004,65:737-738.
  • 4Foley RN, Parfrey PS, Morgan J, et al. Effect of hemoglobin levels in hemodialysis patients with asymptomatic cardiomyopathy. Kidney Int,2000,58 : 1325-1335.
  • 5Foley RN, Parfrey PS, Harnett JD, et al. The impact of anemia on cardiomyopathy, morbidity, and mortality in end-stage renal disease.Am J Kidney Dis, 1996,28:53-61.
  • 6Sarnak MJ. Cardiovascular complications in chronic kidney disease.Am J Kidney Dis, 2003,41 (5 Suppl) : 11-17.
  • 7London G. Pathophysiology of cardiovascular damage in the early renal population. Nephrol Dial Transplant ,2001,16 Suppl 2:3-6.
  • 8Levin A. Prevalence of cardiovascular damage in early renal disease.Nephrol Dial Transplant,2001,16 Suppl 2:7-11.
  • 9Fink J, Blahut S, Reddy M, et al. Use of erythropoietin before the initiation of dialysis and its impact on mortality. Am J Kidney Dis,2001,37:348-355.
  • 10Levy D, Anderson KM, Savage DD, et al. Echocardiographically detected left ventricular hypertrophy: prevalence and risk factors.The Framingham Heart Study. Ann Intern Med, 1988,108:7-13.

共引文献15

同被引文献140

引证文献13

二级引证文献163

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部